Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Fatty acid synthase as a new therapeutic target for HER2-positive gastric cancer.
Cell Oncol (Dordr). 2023 Jun;46(3):661-676. doi: 10.1007/s13402-023-00769-x. Epub 2023 Feb 8.
Cell Oncol (Dordr). 2023.
PMID: 36753044
Free PMC article.
HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness.
Pupa SM, Ligorio F, Cancila V, Franceschini A, Tripodo C, Vernieri C, Castagnoli L.
Pupa SM, et al.
Cancers (Basel). 2021 Sep 24;13(19):4778. doi: 10.3390/cancers13194778.
Cancers (Basel). 2021.
PMID: 34638263
Free PMC article.
Review.
Item in Clipboard
BCL6 and the Notch pathway: a signaling axis leading to a novel druggable biotarget in triple negative breast cancer.
De Santis F, Romero-Cordoba SL, Castagnoli L, Volpari T, Faraci S, Fucà G, Tagliabue E, De Braud F, Pupa SM, Di Nicola M.
De Santis F, et al.
Cell Oncol (Dordr). 2022 Apr;45(2):257-274. doi: 10.1007/s13402-022-00663-y. Epub 2022 Mar 31.
Cell Oncol (Dordr). 2022.
PMID: 35357654
Item in Clipboard
Cite
Cite